Oncological outcomes after transanal total mesorectal excision for rectal cancer
Br J Surg
.
2023 Nov 9;110(12):1614-1617.
doi: 10.1093/bjs/znad168.
Authors
Nader K Francis
1
2
,
Marta Penna
3
4
,
Spyridon Dritsas
1
,
Harry Kinsey
1
,
Brendan Moran
5
,
Deborah Nicol
6
,
Edward Courtney
7
,
Fiona Carter
8
,
Sapho Roodbeen
9
,
Steve Arnold
5
,
Neil Mortensen
3
,
Paul White
10
,
Roel Hompes
11
,
Greg Wynn
12
Affiliations
1
Department of Colorectal Surgery, Yeovil District Hospital Foundation Trust, Yeovil, UK.
2
Division of Surgery and Interventional Science, UCL, London, UK.
3
Department of Colorectal Surgery, Churchill Hospital, University Hospitals of Oxford, Oxford, UK.
4
Department of Surgery and Cancer, Imperial College London, London, UK.
5
Department of Colorectal Surgery, Basingstoke and North Hampshire Hospital, Basingstoke Hospital, Basingstoke, UK.
6
Department of Colorectal Surgery, Worcestershire Royal Hospital, Worcestershire Acute Hospitals NHS Trust, Worcestershire, Worcester, UK.
7
Department of Colorectal Surgery, Royal United Hospital Bath, Bath, UK.
8
Southwest Surgical Training Network Community Interest Company, Yeovil, UK.
9
Department of Colon and Rectal Surgery, Humanitas Clinical and Research Centre, Milan, Italy.
10
Department of Data Science and Mathematics, University of the West of England, Bristol, UK.
11
Department of Surgery, Amsterdam University Medical Centre, Amsterdam, the Netherlands.
12
ICENI Centre, North Essex Foundation Trust, London, UK.
PMID:
37311697
PMCID:
PMC10638524
DOI:
10.1093/bjs/znad168
No abstract available
MeSH terms
Humans
Laparoscopy*
Postoperative Complications / surgery
Proctectomy*
Rectal Neoplasms* / surgery
Rectum / surgery
Transanal Endoscopic Surgery*
Treatment Outcome
Grants and funding
Oxford Colon Cancer Trust